Skip to main content

Mar Tintore Subirana

I am a Neurologist and Head of Care at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since June 2023 I have been Head of Section at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since 2021 I have been a professor of Neurology at the University of Vic-Central University of Catalonia (UVic-UCC).

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Clinical neuroimmunology
General Hospital
Responsable Assistencial
Multiple Sclerosis Centre of Catalonia

Mar Tintore Subirana

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Clinical neuroimmunology
General Hospital
Responsable Assistencial
Multiple Sclerosis Centre of Catalonia

I am a Neurologist and Head of Care at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since June 2023 I have been Head of Section at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since 2021 I have been a professor of Neurology at the University of Vic-Central University of Catalonia (UVic-UCC).

I have developed in particular the study of prognostic factors, multiple sclerosis of the child and adolescent, as well as family planning in women with multiple sclerosis. I am currently a member of the Advisory Ethics Committee (CEA) of the Vall d'Hebron University Hospital.

I have published more than 369 articles in national and international journals and am a regular reviewer of indexed journals both national and international. My factor H is currently 60 and until April 2026 my work has received 26,854 citations.

Projects

REEM - Red Española de Esclerosis Múltiple

IP: REEM - Red Española de Esclerosis Múltiple
Collaborators: Carlos Nos Llopis, REEM - Red Española de Esclerosis Múltiple, Jaume Sastre Garriga, Jordi Rio Izquierdo, Fco. Javier Aymerich Martínez, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Carmen Tur Gomez, Herena Eixarch Ahufinger, Montserrat Moreno Sánchez, Alex Rovira Cañellas, Mar Tintore Subirana, M Jesus Arevalo Navines, Dunia Muñoz Valdivielso, Carmen Espejo Ruiz, Angela Vidal Jordana, Joaquin Castillo Justribo, Mireia Castillo Juarez, Nicolás Miguel Fissolo
Funding agency: Instituto de Salud Carlos III
Funding: 364373.77
Reference: RD07/0060/0020
Duration: 01/01/2008 - 31/12/2014

Espectroscopia por RM de protón e imagen de transferencia de magnetización en el estudio de primeros episodios sugestivos de Esclerosis Múltiple.

IP: -
Collaborators: Alex Rovira Cañellas, Mar Tintore Subirana, Espectroscopia por RM de protón e imagen de transferencia de magnetización en el estudio de primeros episodios sugestivos de Esc
Funding agency: Instituto de Salud Carlos III
Funding: 40940
Reference: PI020971
Duration: 06/11/2002 - 31/12/2005

Estudio de genes candidatos en regiones de susceptibilidad para la esclerosis múltiple

IP: Manuel Comabella Lopez
Collaborators: Mar Tintore Subirana
Funding agency: Instituto de Salud Carlos III
Funding: 131890
Reference: PI061906
Duration: 01/01/2007 - 30/06/2010

Análisis proteómico en líquido cefaloraquídeo y suero de pacientes con síndromes clínicos aislados sugestivos de esclerosis múltiple

IP: Mar Tintore Subirana
Collaborators: Manuel Comabella Lopez, Análisis proteómico en líquido cefaloraquídeo y suero de pacientes con síndromes clínicos aislados sugestivos de esclerosis múlt
Funding agency: Instituto de Salud Carlos III
Funding: 141015
Reference: PI050588
Duration: 01/01/2006 - 31/01/2009

Related news

The Spider-MS tool estimates the probability that a patient will experience various long-term clinical events and will help personalize the follow-up and treatment of each person living with the disease.

The results show that live attenuated vaccines against measles, rubella, mumps and varicella do not increase the risk of relapses in people with multiple sclerosis.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Related professionals

Borja González Rodríguez

Borja González Rodríguez

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Herminio Garcia Miguelez

Herminio Garcia Miguelez

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more
Montse Rodriguez Gomez

Montse Rodriguez Gomez

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more
Elena Valdivia Garcia

Elena Valdivia Garcia

Predoctoral researcher
Transfusional Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.